Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et al.

被引：1

作者：

Ikeda, M. ^{[1
]}

Shimizu, S. ^{[1
]}

Sato, T. ^{[2
]}

Morimoto, M. ^{[3
]}

Kojima, Y. ^{[4
]}

Inaba, Y. ^{[5
]}

Hagihara, A. ^{[6
]}

Kudo, M. ^{[7
]}

Nakamori, S. ^{[8
]}

Kaneko, S. ^{[9
]}

Sugimoto, R. ^{[10
]}

Tahara, T. ^{[11
]}

Ohmura, T. ^{[12
]}

Yasui, K. ^{[13
]}

Sato, K. ^{[14
]}

Ishii, H. ^{[15
]}

Furuse, J. ^{[16
]}

Okusaka, T. ^{[17
]}

机构：

[1] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan

[2] Kyoto Univ, Dept Biostat, Sch Publ Hlth, Kyoto, Japan

[3] Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa, Japan

[4] Natl Ctr Global Hlth & Med Ctr Hosp, Dept Gastroenterol, Tokyo, Japan

[5] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi, Japan

[6] Osaka City Univ Hosp, Dept Hepatol, Osaka, Japan

[7] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka, Japan

[8] Osaka Natl Hosp, Dept Hepatobiliary & Pancreat Surg, Osaka, Japan

[9] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan

[10] Natl Hosp Org Kyushu Canc Ctr, Dept Hepatobiliary Pancreatol, Fukuoka, Japan

[11] Saiseikai Utsunomiya Hosp, Dept Gastroenterol, Utsunomiya, Tochigi, Japan

[12] Sapporo Kosei Gen Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan

[13] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan

[14] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Kyoto, Japan

[15] Shikoku Canc Ctr, Clin Res Ctr, Matsuyama, Ehime, Japan

[16] Kyorin Univ, Dept Med Oncol, Tokyo, Japan

[17] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷 / 04期

关键词：

CELL;

D O I：

10.1093/annonc/mdx013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：903 / 904

页数：3

共 50 条

[41] Lenvatinib plus hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma.
Yamamoto, Makoto
Terashima, Takeshi
Yamashita, Tatsuya
Yanagi, Masahiro
Nakagawa, Hidetoshi
Seki, Akihiro
Nio, Kouki
Arai, Kuniaki
Toyama, Tadashi
Yamashita, Taro
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 496 - 496
[42] A PHASE II TRIAL OF HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH CISPLATIN FOR ADVANCED HEPATOCELLULAR CARCINOMA WITH PORTAL VEIN TUMOR THROMBOSIS
Furuse, J.
Ikeda, M.
Okusaka, T.
Nakachi, K.
Morizane, C.
Ueno, H.
Yamaura, H.
Inaba, Y.
Satake, M.
Arai, Y.
[J]. ANNALS OF ONCOLOGY, 2008, 19 : 178 - 178
[43] Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
Lyu, Ning
Kong, Yanan
Mu, Luwen
Lin, Youen
Li, Jibin
Liu, Yaru
Zhang, Zhenfeng
Zheng, Lie
Deng, Haijing
Li, Shaolong
Xie, Qiankun
Guo, Rongping
Shi, Ming
Xu, Li
Cai, Xiuyu
Wu, Peihong
Zhao, Ming
[J]. JOURNAL OF HEPATOLOGY, 2018, 69 (01) : 60 - 69
[44] Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
Hatooka, Masahiro
Kawaoka, Tomokazu
Aikata, Hiroshi
Inagaki, Yuki
Morio, Kei
Nakahara, Takashi
Murakami, Eisuke
Tsuge, Masataka
Hiramatsu, Akira
Imamura, Michio
Kawakami, Yoshiiku
Awai, Kazuo
Masaki, Keiichi
Waki, Koji
Kohno, Hirotaka
Kohno, Hiroshi
Moriya, Takashi
Nagaoki, Yuko
Tamura, Toru
Amano, Hajime
Katamura, Yoshio
Chayama, Kazuaki
[J]. BMC CANCER, 2018, 18
[45] Phase I/II study of sorafenib in combination with intermittent hepatic arterial infusion chemotherapy using cisplatin for unresectable advanced hepatocellular carcinoma with portal vein tumor thrombus
Ishizaki, Morihiko
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
[46] Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy
Miyaki, Daisuke
Aikata, Hiroshi
Kan, Hiromi
Fujino, Hatsue
Urabe, Ayako
Masaki, Keiichi
Fukuhara, Takayuki
Kobayashi, Tomoki
Naeshiro, Noriaki
Nakahara, Takashi
Kawaoka, Tomokazu
Hiramatsu, Akira
Takahashi, Shoichi
Ishikawa, Masaki
Kakizawa, Hideaki
Awai, Kazuo
Chayama, Kazuaki
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (12) : 1834 - 1841
[47] Comparison of Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: A Propensity Score Matching: Study
Shiozawa, Kazue
Watanabe, Manabu
Ikehara, Takashi
Kogame, Michio
Matsui, Teppei
Okano, Naoki
Kikuchi, Yoshinori
Nagai, Hidenari
Ishii, Koji
Makino, Hiroyuki
Igarashil, Yoshinori
Sumino, Yasukiyo
[J]. HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 885 - 891
[48] Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series
Nemoto, Tomoyuki
Matsuda, Hidetaka
Nosaka, Takuto
Saito, Yasushi
Ozaki, Yoshihiko
Hayama, Ryoko
Naito, Tatsushi
Takahashi, Kazuto
Ofuji, Kazuya
Ohtani, Masahiro
Hiramatsu, Katsushi
Suto, Hiroyuki
Nakamoto, Yasunari
[J]. MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1028 - 1034
[49] Moving beyond sorafenib alone in advanced hepatocellular carcinoma: is hepatic arterial infusion chemotherapy the best option?
Fornaro, L.
Vivaldi, C.
Lorenzoni, G.
Masi, G.
Bargellini, I.
[J]. ANNALS OF ONCOLOGY, 2017, 28 (03) : 667 - 667
[50] Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
Masahiro Hatooka
Tomokazu Kawaoka
Hiroshi Aikata
Yuki Inagaki
Kei Morio
Takashi Nakahara
Eisuke Murakami
Masataka Tsuge
Akira Hiramatsu
Michio Imamura
Yoshiiku Kawakami
Kazuo Awai
Keiichi Masaki
Koji Waki
Hirotaka Kohno
Hiroshi Kohno
Takashi Moriya
Yuko Nagaoki
Toru Tamura
Hajime Amano
Yoshio Katamura
Kazuaki Chayama
[J]. BMC Cancer, 18

← 1 2 3 4 5 →